Zante Greg

Viking Therapeutics, Inc. ยท Chief Financial Officer

Zante Greg is listed in public filings as officer: Chief Financial Officer. This Zante Greg insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Viking Therapeutics, Inc. (VKTX). Investors use Zante Greg's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Viking Therapeutics, Inc.VKTX$7.0M215.6k sharesSellJan 5, 2026$1.0M32k shares$32.30--
Viking Therapeutics, Inc.VKTX$6.7M201.7k sharesSellJan 5, 2026$464.0K13.9k shares$33.38--
Viking Therapeutics, Inc.VKTX$6.6M191.4k sharesSellJan 5, 2026$352.6K10.3k shares$34.24--
Viking Therapeutics, Inc.VKTX$6.1M189.9k sharesSellJan 5, 2026$48.1K1.5k shares$32.09--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Viking Therapeutics, Inc.VKTX$3.2M91k sharesGrant / ExerciseJan 2, 2026$3.2M91k shares$35.42--
Viking Therapeutics, Inc.VKTX--215.5k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable41k shares----
Viking Therapeutics, Inc.VKTX--247.5k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable32k shares----
Viking Therapeutics, Inc.VKTX$6.1M173.6k sharesSellOct 28, 2025$216.5K6.2k shares$35.00--
Viking Therapeutics, Inc.VKTX--179.8k sharesGrant / ExerciseOct 27, 2025Disclosure amount unavailable11.1k shares----
Viking Therapeutics, Inc.VKTX$4.7M168.7k sharesSellJul 3, 2025$118.4K4.3k shares$27.76--
Viking Therapeutics, Inc.VKTX--172.9k sharesGrant / ExerciseJul 2, 2025Disclosure amount unavailable7.7k shares----
Viking Therapeutics, Inc.VKTX$7.3M170k sharesSellJan 6, 2025$1.9M45.6k shares$42.69--
Viking Therapeutics, Inc.VKTX$7.2M165.3k sharesSellJan 6, 2025$203.6K4.7k shares$43.32--
Viking Therapeutics, Inc.VKTX$1.6M37.2k sharesGrant / ExerciseJan 3, 2025$1.6M37.2k shares$42.89--
Viking Therapeutics, Inc.VKTX--193.9k sharesGrant / ExerciseJan 3, 2025Disclosure amount unavailable44.5k shares----
Viking Therapeutics, Inc.VKTX--215.6k sharesGrant / ExerciseJan 3, 2025Disclosure amount unavailable21.7k shares----
Viking Therapeutics, Inc.VKTX$17M231.4k sharesSellOct 28, 2024$3.7M49.7k shares$74.56--
Viking Therapeutics, Inc.VKTX$14M180.4k sharesSellOct 28, 2024$1.8M23.1k shares$77.68--
Viking Therapeutics, Inc.VKTX$16M212.8k sharesSellOct 28, 2024$1.4M18.6k shares$75.79--
Viking Therapeutics, Inc.VKTX$13M164.6k sharesSellOct 28, 2024$1.2M15.8k shares$78.69--
Viking Therapeutics, Inc.VKTX$16M203.5k sharesSellOct 28, 2024$712.8K9.3k shares$76.94--
Viking Therapeutics, Inc.VKTX$12M150.6k sharesSellOct 28, 2024$642.5K8k shares$80.65--
Viking Therapeutics, Inc.VKTX$13M158.5k sharesSellOct 28, 2024$482.7K6.1k shares$79.78--
Viking Therapeutics, Inc.VKTX$1.3M153k sharesGrant / ExerciseOct 28, 2024$434.5K51k shares$8.52--
Viking Therapeutics, Inc.VKTX$026k sharesGrant / ExerciseOct 28, 2024$150.8K26k shares$5.80--
Viking Therapeutics, Inc.VKTX$012.8k sharesGrant / ExerciseOct 28, 2024$99.1K12.8k shares$7.77--
Viking Therapeutics, Inc.VKTX$12M149.4k sharesSellOct 28, 2024$98.2K1.2k shares$81.44--
Viking Therapeutics, Inc.VKTX$04.3k sharesGrant / ExerciseOct 28, 2024$19.9K4.3k shares$4.68--
Viking Therapeutics, Inc.VKTX$11M190.5k sharesSellJul 30, 2024$721.2K12.7k shares$56.96--
Viking Therapeutics, Inc.VKTX$11M187.6k sharesSellJul 30, 2024$171.6K3k shares$57.71--
Viking Therapeutics, Inc.VKTX$11M187.1k sharesSellJul 30, 2024$29.4K500 shares$58.71--
Viking Therapeutics, Inc.VKTX--181.5k sharesGrant / ExerciseJul 29, 2024Disclosure amount unavailable6.7k shares----
Viking Therapeutics, Inc.VKTX--203.2k sharesGrant / ExerciseJul 29, 2024Disclosure amount unavailable21.7k shares----